Kymera Therapeutics, Inc. (KYMR) quarterly income statement — complete revenue, gross profit & net income history
Kymera Therapeutics, Inc. (KYMR) annual income statement — 8-year revenue, gross profit & net income history
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Sales/Revenue | 65M | 34.37M | 2.86M | 2.76M | 11.48M | 22.1M | 7.39M | 3.74M | 25.65M | 10.29M | 47.88M | 4.73M | 16.51M | 9.47M | 16.14M | 9.55M | 11.51M | 9.62M | 15.28M | 20.34M |
| Revenue Growth % | 466.4% | 55.5% | -61.32% | -26.12% | -55.26% | 114.83% | -84.56% | -20.88% | 55.33% | 8.67% | 196.7% | -50.5% | 43.42% | -1.62% | 5.66% | -53.03% | -37.83% | -48.55% | 19.48% | 39.93% |
| Cost of Goods Sold | 0 | 0 | -76.18M | 74.09M | 2.08M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | -2663.57% | 2680.68% | 18.16% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 65M | 34.37M | 79.04M | -71.33M | 9.39M | 22.1M | 7.39M | 3.74M | 25.65M | 10.29M | 47.88M | 4.73M | 16.51M | 9.47M | 16.14M | 9.55M | 11.51M | 9.62M | 15.28M | 20.34M |
| Gross Margin % | 100% | 100% | 2763.57% | -2580.68% | 81.84% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Gross Profit Growth % | 592.08% | 55.5% | 968.95% | -2006.71% | -63.38% | 114.83% | -84.56% | -20.88% | 55.33% | 8.67% | 196.7% | -50.5% | 43.42% | -1.62% | 5.66% | -53.03% | -37.83% | -48.55% | 19.48% | 39.93% |
| Operating Expenses | 140.61M | 118.52M | 176.93M | 21.19M | 93.95M | 96.53M | 88.15M | 75.86M | 76.58M | 68.12M | 67.2M | 62.24M | 59.9M | 54.79M | 54.77M | 54.43M | 52.32M | 46.55M | 49.27M | 48.97M |
| OpEx % of Revenue | 216.32% | 344.88% | 6186.5% | 766.68% | 818.66% | 436.77% | 1192.17% | 2027.93% | 298.54% | 662.18% | 140.33% | 1316.35% | 362.72% | 578.83% | 339.36% | 569.92% | 454.44% | 483.84% | 322.55% | 240.82% |
| Selling, General & Admin | 21.13M | 20.36M | 16.95M | 17.34M | 17.64M | 16.27M | 16.33M | 15.46M | 17.37M | 14.37M | 14.23M | 14.12M | 14.13M | 12.56M | 11.64M | 10.56M | 11.03M | 10.61M | 11.74M | 10.67M |
| SG&A % of Revenue | 32.5% | 59.24% | 592.59% | 627.21% | 153.76% | 73.62% | 220.88% | 413.12% | 67.73% | 139.73% | 29.71% | 298.65% | 85.56% | 132.74% | 72.1% | 110.52% | 95.81% | 110.28% | 76.86% | 52.45% |
| Research & Development | 119.48M | 98.16M | 83.86M | 74.09M | 78.39M | 80.25M | 71.82M | 60.41M | 59.2M | 48.82M | 52.97M | 48.12M | 45.77M | 42.23M | 43.13M | 43.88M | 41.29M | 35.94M | 37.53M | 38.31M |
| R&D % of Revenue | 183.82% | 285.65% | 2932.27% | 2680.68% | 683.06% | 363.14% | 971.29% | 1614.81% | 230.81% | 474.57% | 110.62% | 1017.7% | 277.16% | 446.09% | 267.26% | 459.4% | 358.63% | 373.56% | 245.7% | 188.37% |
| Other Operating Expenses | 0 | 0 | 1000K | -1000K | -1000K | 0 | 0 | 0 | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -75.61M | -84.15M | -97.9M | -92.52M | -84.56M | -74.43M | -80.75M | -72.12M | -50.92M | -57.83M | -19.31M | -57.51M | -43.38M | -45.33M | -38.63M | -44.88M | -40.81M | -36.93M | -33.99M | -28.64M |
| Operating Margin % | -116.32% | -244.88% | -3422.94% | -3347.36% | -736.82% | -336.77% | -1092.17% | -1927.93% | -198.54% | -562.18% | -40.33% | -1216.35% | -262.72% | -478.83% | -239.36% | -469.92% | -354.44% | -383.84% | -222.55% | -140.82% |
| Operating Income Growth % | 10.58% | -13.07% | -21.23% | -28.28% | -66.04% | -28.7% | -318.16% | -25.41% | -17.38% | -27.59% | 50.01% | -28.13% | -6.3% | -22.72% | -13.64% | -56.73% | -65.02% | -180.45% | -165.95% | -254.29% |
| EBITDA | -61.13M | -82.13M | -95.86M | -89.67M | -82.47M | -72.38M | -78.77M | -70.14M | -48.99M | -56.37M | -18.45M | -56.61M | -42.48M | -44.43M | -37.81M | -44.12M | -40.1M | -36.25M | -33.3M | -27.97M |
| EBITDA Margin % | -94.05% | -239% | -3351.89% | -3244.28% | -718.66% | -327.5% | -1065.3% | -1874.82% | -190.98% | -547.97% | -38.52% | -1197.31% | -257.27% | -469.32% | -234.29% | -461.89% | -348.32% | -376.7% | -218.04% | -137.52% |
| EBITDA Growth % | 25.88% | -13.48% | -21.7% | -27.85% | -68.36% | -28.4% | -327% | -23.9% | -15.31% | -26.89% | 51.21% | -28.32% | -5.93% | -22.57% | -13.53% | -57.75% | -65.87% | -185.76% | -171.1% | -268.31% |
| D&A (Non-Cash Add-back) | 0 | 2.02M | 2.03M | 2.85M | 2.08M | 2.05M | 1.99M | 1.99M | 1.94M | 1.46M | 865K | 900K | 900K | 900K | 818K | 767K | 705K | 687K | 689K | 671K |
| EBIT | -61.13M | -69.17M | -87.18M | -82.17M | -76.51M | -65.51M | -70.69M | -62.43M | -42M | -48.49M | -14.32M | -52.83M | -38.75M | -40.87M | -34.81M | -42.97M | -40.22M | -36.64M | -33.85M | -28.51M |
| Net Interest Income | 14.4M | 14.92M | 10.64M | 10.35M | 7.94M | 8.85M | 10M | 9.64M | 8.86M | 9.27M | 4.94M | 4.64M | 4.58M | 4.4M | 3.77M | 1.88M | 553K | 249K | 94K | 55K |
| Interest Income | 14.48M | 14.98M | 10.71M | 10.35M | 8.05M | 8.92M | 10.06M | 9.7M | 8.92M | 9.34M | 5M | 4.68M | 4.63M | 4.45M | 3.82M | 1.92M | 594K | 290K | 144K | 125K |
| Interest Expense | 81K | 61K | 69K | 0 | 108K | 72K | 59K | 60K | 61K | 69K | 52K | 41K | 48K | 55K | 58K | 36K | 41K | 41K | 50K | 70K |
| Other Income/Expense | 14.4M | 14.92M | 10.64M | 10.35M | 7.94M | 8.85M | 10M | 9.64M | 8.86M | 9.27M | 4.94M | 4.64M | 4.58M | 4.4M | 3.77M | 1.88M | 553K | 249K | 94K | 55K |
| Pretax Income | -61.21M | -69.23M | -87.25M | -82.17M | -76.61M | -65.58M | -70.75M | -62.49M | -42.06M | -48.56M | -14.37M | -52.87M | -38.8M | -40.93M | -34.87M | -43M | -40.26M | -36.68M | -33.9M | -28.58M |
| Pretax Margin % | -94.17% | -201.47% | -3050.8% | -2973.05% | -667.6% | -296.75% | -956.88% | -1670.33% | -163.98% | -472.02% | -30.01% | -1118.17% | -234.96% | -432.37% | -216.03% | -450.24% | -349.64% | -381.25% | -221.93% | -140.55% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -61.21M | -69.23M | -87.03M | -82.17M | -76.61M | -65.58M | -70.75M | -62.49M | -42.06M | -48.56M | -14.37M | -52.87M | -38.8M | -40.93M | -34.87M | -43M | -40.26M | -36.68M | -33.9M | -28.58M |
| Net Margin % | -94.17% | -201.47% | -3043.01% | -2973.05% | -667.6% | -296.75% | -956.88% | -1670.33% | -163.98% | -472.02% | -30.01% | -1118.17% | -234.96% | -432.37% | -216.03% | -450.24% | -349.64% | -381.25% | -221.94% | -140.55% |
| Net Income Growth % | 20.1% | -5.57% | -23.01% | -31.51% | -82.15% | -35.06% | -392.43% | -18.2% | -8.41% | -18.64% | 58.79% | -22.94% | 3.62% | -11.57% | -2.84% | -50.45% | -63.25% | -180.57% | -167.25% | -257.9% |
| Net Income (Continuing) | -61.21M | -69.23M | -87.25M | -82.17M | -76.61M | -65.58M | -70.75M | -62.49M | -42.06M | -48.56M | -14.37M | -52.87M | -38.8M | -40.93M | -34.87M | -43M | -40.26M | -36.68M | -33.9M | -28.58M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.62 | -0.71 | -0.98 | -0.94 | -0.95 | -0.82 | -0.88 | -0.82 | -0.58 | -0.69 | -0.25 | -0.90 | -0.67 | -0.63 | -0.59 | -0.79 | -0.77 | -0.71 | -0.66 | -0.56 |
| EPS Growth % | 34.74% | 13.41% | -11.36% | -14.63% | -63.79% | -18.84% | -252% | 8.89% | 13.43% | -9.52% | 57.63% | -13.92% | 12.99% | 11.27% | 10.61% | -41.07% | -40% | -144.83% | -127.59% | -211.11% |
| EPS (Basic) | -0.62 | -0.71 | -0.98 | -0.94 | -0.95 | -0.82 | -0.88 | -0.82 | -0.58 | -0.69 | -0.25 | -0.90 | -0.67 | -0.63 | -0.59 | -0.79 | -0.77 | -0.71 | -0.66 | -0.56 |
| Diluted Shares Outstanding | 98.18M | 97.53M | 84.39M | 87.3M | 80.45M | 80.15M | 79.99M | 76.13M | 73.06M | 70.77M | 58.52M | 58.42M | 58.33M | 58.19M | 57.89M | 54.54M | 51.77M | 51.65M | 51.39M | 50.71M |
| Basic Shares Outstanding | 98.18M | 97.53M | 84.39M | 87.3M | 80.45M | 80.15M | 79.99M | 76.13M | 73.06M | 70.77M | 58.52M | 58.42M | 58.33M | 58.19M | 57.89M | 54.54M | 51.77M | 51.65M | 51.39M | 50.71M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |